Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic
- PMID: 35892928
- PMCID: PMC9326743
- DOI: 10.3390/biotech11030023
Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic
Abstract
Translational science has been introduced as the nexus among the scientific and the clinical field, which allows researchers to provide and demonstrate that the evidence-based research can connect the gaps present between basic and clinical levels. This type of research has played a major role in the field of cardiovascular diseases, where the main objective has been to identify and transfer potential treatments identified at preclinical stages into clinical practice. This transfer has been enhanced by the intromission of digital health solutions into both basic research and clinical scenarios. This review aimed to identify and summarize the most important translational advances in the last years in the cardiovascular field together with the potential challenges that still remain in basic research, clinical scenarios, and regulatory agencies.
Keywords: cardiovascular diseases; digital health; translational medicine.
Conflict of interest statement
Fernández-Avilés and Atienza have equity from Corify Care SL. Atienza and Arenal served on the advisory board of Medtronic. None of the other authors has any conflict of interest, financial or otherwise, to disclose.
Figures



References
Publication types
Grants and funding
- PI16/01123, , DTS16/0160, PI17/01059, PI19/00161, PI20/01618, DTS21/00064 and PI18/01895/Instituto de Salud Carlos III
- Red TERCEL RETIC RD16/0011/0029/Instituto de Salud Carlos III
- RICORS RD21/0017 and TERAV (Group: 002)/Instituto de Salud Carlos III
- S2017/BMD-3962, Avancell-CM/Comunidad de Madrid
- Centro de Investigación en Red en Enfermedades Cardiovasculares
LinkOut - more resources
Full Text Sources
Miscellaneous